Nicorandil - an Effective Multitarget Drug for Cardioprotection?
- PMID: 36301452
- DOI: 10.1007/s10557-022-07397-x
Nicorandil - an Effective Multitarget Drug for Cardioprotection?
Comment on
-
Nicorandil Suppresses Ischemia-Induced Norepinephrine Release and Ventricular Arrhythmias in Hypertrophic Hearts.Cardiovasc Drugs Ther. 2023 Feb;37(1):53-62. doi: 10.1007/s10557-022-07369-1. Epub 2022 Jul 27. Cardiovasc Drugs Ther. 2023. PMID: 35895166
References
-
- Davidson SM, Ferdinandy P, Andreadou I, et al. Multitarget strategies to reduce myocardial ischemia/reperfusion injury: JACC review topic of the week. J Am Coll Cardiol. 2019;73(1):89–99. - DOI
-
- Kobara M, Amano T, Toba H, Nakata T. Nicorandil suppresses ischemia-induced norepinephrine release and ventricular arrhythmias in hypertrophic hearts. Cardiovasc Drugs Ther. 2022.
-
- Qian G, Zhang Y, Dong W, et al. Effects of nicorandil administration on infarct size in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the CHANGE trial. J Am Heart Assoc. 2022;11(18):e026232. - DOI
-
- Ong MEH, Perkins GD, Cariou A. Out-of-hospital cardiac arrest: prehospital management. Lancet. 2018;391(10124):980–8. - DOI
-
- Horinaka S, Kobayashi N, Yabe A, et al. Nicorandil protects against lethal ischemic ventricular arrhythmias and up-regulates endothelial nitric oxide synthase expression and sulfonylurea receptor 2 mRNA in conscious rats with acute myocardial infarction. Cardiovasc Drugs Ther. 2004;18(1):13–22. - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources